Showing results (61-70 of 69) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Molecules (Basel, Switzerland)|March 11, 2023
BF2-Azadipyrromethene Fluorophores for Intraoperative Vital Structure IdentificationCathal Caulfield, Dan Wu, Ian S Miller, et al.Pharmacoeconomics|February 4, 2026
Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and SpainJonathan Briody, Ian S Miller, James F O'Mahony, et al.Ebiomedicine|July 14, 2019
Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor AElke Burgermeister, Francesca Battaglin, Fagr Eladly, et al.Cancer Medicine|April 18, 2022
Implementing subtype-specific pre-clinical models of breast cancer to study pre-treatment aspirin effectsIan S Miller, Sonja Khan, Liam P Shiels, et al.European Journal of Radiology|July 1, 2026
Co-clinical CT radiomics pipeline to establish candidate imaging biomarkers for colorectal cancerKate Connor, Olivia Prior, Liam P Shiels, et al.Cancers|October 17, 2020
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft ModelsAlice C O'Farrell, Monika A Jarzabek, Andreas U Lindner, et al.NPJ Genomic Medicine|May 29, 2024
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patientsTom Venken, Ian S Miller, Ingrid Arijs, et al.Plos One|January 28, 2017
A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib MalateAlice C O'Farrell, Rhys Evans, Johanna M U Silvola, et al.Nature Communications|October 7, 2018
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapyDominiek Smeets, Ian S Miller, Darran P O'Connor, et al.Pageof 7